We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GCBC icon
4626
Greene County Bancorp
GCBC
$584M
$6K ﹤0.01%
402
-862
-68% -$11.5K
GEG icon
4627
Great Elm Group
GEG
$67.4M
$6K ﹤0.01%
2,767
+1,957
+242% +$4.98K
GSG icon
4628
iShares S&P GSCI Commodity-Indexed Trust
GSG
$936M
$6K ﹤0.01%
400
+259
+184% +$3.94K
IPAY icon
4629
Amplify Mobile Payments ETF
IPAY
$182M
$6K ﹤0.01%
90
KOLD icon
4630
ProShares UltraShort Bloomberg Natural Gas
KOLD
$98.3M
$6K ﹤0.01%
28
-1,254
-98% -$403K
LITB
4631
LightInTheBox
LITB
$56M
$6K ﹤0.01%
+500
New +$8.01K
LTRX icon
4632
Lantronix
LTRX
$256M
$6K ﹤0.01%
1,214
-1,176
-49% -$6.09K
LVTX
4633
DELISTED
LAVA Therapeutics
LVTX
$6K ﹤0.01%
+557
New +$6.9K
NMR icon
4634
Nomura Holdings
NMR
$28.7B
$6K ﹤0.01%
+1,274
New +$6.85K
ONCY
4635
Oncolytics Biotech
ONCY
$95.8M
$6K ﹤0.01%
+2,160
New +$6.62K
ORN icon
4636
Orion Group Holdings
ORN
$396M
$6K ﹤0.01%
991
-3,243
-77% -$18.9K
PFLT icon
4637
PennantPark Floating Rate Capital
PFLT
$734M
$6K ﹤0.01%
434
-1,187
-73% -$15K
PHGE icon
4638
BiomX
PHGE
$1.78M
$6K ﹤0.01%
+6
New +$6.98K
REPX icon
4639
Riley Exploration Permian
REPX
$802M
$6K ﹤0.01%
221
+211
+2,110% +$7.52K
SACH
4640
Sachem Capital Corp
SACH
$38.6M
$6K ﹤0.01%
1,129
-1,558
-58% -$8.11K
SEED icon
4641
Origin Agritech
SEED
$13M
$6K ﹤0.01%
738
-1,033
-58% -$13K
SRTS icon
4642
Sensus Healthcare
SRTS
$50.9M
$6K ﹤0.01%
1,623
-5,077
-76% -$19K
TIL icon
4643
Instil Bio
TIL
$50.3M
$6K ﹤0.01%
16
-147
-90% -$54.5K
TPST icon
4644
Tempest Therapeutics
TPST
$16.6M
$6K ﹤0.01%
+45
New +$10.1K
UXIN
4645
Uxin Ltd
UXIN
$257M
$6K ﹤0.01%
+15
New +$4.53K
VIOT
4646
Viomi Technology
VIOT
$49.5M
$6K ﹤0.01%
+684
New +$5.56K
VRP icon
4647
Invesco Variable Rate Preferred ETF
VRP
$3.01B
$6K ﹤0.01%
224
YCBD icon
4648
cbdMD
YCBD
$5.94M
$6K ﹤0.01%
+6
New +$7.18K
NTRP icon
4649
NextTrip
NTRP
$22.7M
$6K ﹤0.01%
+79
New +$5.85K
CYTH
4650
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
$6K ﹤0.01%
565
+371
+191% +$3.11K

Similar funds

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.